Loading...
 

Volume 30, Issue 3, September 2019






Sign in to download the Issue in PDF format.

 


Mediterr J Rheumatol 2019;30(3):190-3
Α 40-Year-Old Woman with Asymmetric Arthritis and Skin Lesions
Authors Information
1Patras University Hospital, Department of Internal Medicine, Division of Rheumatology, Rion, Patras, Greece
2University of Patras Medical School, Rion, Patras, Greece
References
  1. Bachmeyer C, Vigouroux A, Moguelet P. Fever, arthritis, and cutaneous lesions. Eur J Intern Med 2017;Dec;46:e3-e4. [https://doi.org/10.1016/j.ejim.2017.04.023] [PMID: 28483370]
  2. Jacques T, Sudoł-Szopińska I, Larkman N, O’Connor P, Cotten A. Musculoskeletal Manifestations of Non-RA Connective Tissue Diseases: Scleroderma, Systemic Lupus Erythematosus, Still’s Disease, Dermatomyositis/Polymyositis, Sjögren’s Syndrome, and Mixed Connective Tissue Disease. Semin Musculoskelet Radiol 2018;Apr;22(2):166-79. [https://doi.org/10.1055/s-0038-1639473] [PMID: 29672805]
  3. Boswell SB, Patel DB, White EA, Gottsegen CJ, Forrester DM, Masih S, et al. Musculoskeletal manifestations of endocrine disorders. Clinical Imaging 2014;Jul-Aug;38(4):384-96. [https://doi.org/10.1016/j.clinimag.2014.02.014] [PMID: 24642251]
  4. Morais SA, du Preez HE, Akhtar MR, Cross S, Isenberg DA. Musculoskeletal complications of haematological disease. Rheumatology (Oxford) 2016; Jun;55(6):968-81. [https://doi.org/10.1093/rheumatology/kev360] [PMID: 26443208]
  5. Wen J, Ouyang H, Yang R, Bo L, Zhang Y, Tang M, et al. Malignancy dominated with rheumatic manifestations: A retrospective single-center analysis. Sci Rep 2018;8, Article 1786. [https://doi.org/10.1038/s41598-018-20167-w]
  6. Chen JH, Li CJ, Zhi M. Extraintestinal manifestations of inflammatory bowel disease. World Chinese J Dig 2016. [https://doi.org/10.11569/wcjd.v24.i1.1]
  7. Vavricka SR, Rogler G, Gantenbein C, Spoerri M, Vavricka MP, Navarini AA, et al. Chronological order of appearance of extraintestinal manifestations relative to the time of IBD diagnosis in the Swiss Inflammatory Bowel Disease Cohort. Inflamm Bowel Dis 2015;2015 Aug;21(8):1794-800. [https://doi.org/10.1097/MIB.0000000000000429] [PMID: 26020601]
  8. Atzeni F, Defendenti C, Ditto MC, Batticciotto A, Ventura D, Antivalle M, et al. Rheumatic manifestations in inflammatory bowel disease. Autoimmun Rev 2014;Jan;13(1):20-3. [https://doi.org/10.1016/j.autrev.2013.06.006] [PMID: 23774109]
  9. Ye MJ, Ye JM. Pyoderma gangrenosum: A review of clinical features and outcomes of 23 cases requiring inpatient management. Dermatol Res Pract 2014;2014:461467. [https://doi.org/10.1155/2014/461467] [PMID: 25374597] [PMCID: PMC4206920]
  10. Suvirya S, Pathania S, Singhai A. A case of bullous pyoderma gangrenosum. BMJ Case Rep 2019;Mar 31;12(3):pii: e228772. [https://doi.org/10.1136/bcr-2018-228772] [PMID: 30936355]
  11. Roth N, Biedermann L, Fournier N, Butter M, Vavricka SR, Navarini AA, et al. Occurrence of skin manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study. PLoS One 2019; 14(1):e0210436. [https://doi.org/10.1371/journal.pone.0210436] [PMID: 30682031] [PMCID: PMC6347222]
  12. Atzeni F, Defendenti C, Ditto MC, Batticciotto A, Ventura D, Antivalle M, et al. Rheumatic manifestations in inflammatory bowel disease. Autoimmun Rev 2014 Jan;13(1):20-3. [https://doi.org/10.1016/j.autrev.2013.06.006] [PMID: 23774109]
  13. Hiller A, Biedermann L, Fournier N, Butter M, Vavricka SR, Ciurea A, et al. The appearance of joint manifestations in the Swiss inflammatory bowel disease cohort. PLoS One 2019;14(4):e0211554. [https://doi.org/10.1371/journal.pone.0211554] [PMID: 31039159] [PMCID: PMC6490952]
  14. Gameiro A, Pereira N, Cardoso JC, Gonçalo M. Pyoderma gangrenosum: Challenges and solutions. Clin Cosmet Investig Dermatol 2015 May 28;8:285-93. [https://doi.org/10.2147/CCID.S61202] [PMID: 26060412] [PMCID: PMC4454198]  
  15. Ye MJ, Ye JM. Pyoderma gangrenosum: A review of clinical features and outcomes of 23 cases requiring inpatient management. Dermatol Res Pract 2014;2014:461467. [https://doi.org/10.1155/2014/461467] [PMID: 25374597] [PMCID: PMC4206920]
  16. Suvirya S, Pathania S, Singhai A. A case of bullous pyoderma gangrenosum. BMJ Case Reports 2019;12(3). pii: e228772. [https://doi.org/10.1136/bcr-2018-228772] [PMID: 30936355]
  17. Lakatos PL, Lakatos L, Kiss LS, Peyrin-Biroulet L, Schoepfer A, Vavricka S. Treatment of extraintestinal manifestations in inflammatory bowel disease. Digestion 2012;86 Suppl 1:28-35. [https://doi.org/10.1159/000341950] [PMID: 23051724]
  18. Vavricka S, Scharl M, Gubler M, Rogler G. Biologics for Extraintestinal Manifestations of IBD. Curr Drug Targets 2014;15(11):1064-73. [https://doi.org/10.2174/1389450115666140908125453] [PMID: 25198785]